Flashback [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2012-04-05 18:10 (4375 d 05:44 ago) – Posting: # 8386
Views: 9,458

Hi John!

❝ This just popped into my head (flashback... Nightmare, whatever you called it)...


For me – flashback. We performed a pilot study of a drug with a nice average [sic] half-life of ~50 hours, sampling up to 216 hours (since truncated AUC wasn’t common at that time), washout 2 weeks. No predose concentrations… The pivotal was a 6×3 in 36 subjects, but:Result: We measured pre-dose values (maximum 7.8% of Cmax) in 54% of samples of periods 2 & 3 (none in period 1). Since we had a blinded plausibility review in place we were able to come up with a statistical amendment while analytics were still running:Results:Lessons learned: Never base the washout on mean-values (large studies not even on x±SD) and think twice if you improve the analytical method too much. ;-)

P.S.: The product was approved based on this study in the EU in 2002 and by the FDA in 2003.

❝ Should the lab adjust the concentration profile to remove the residual levels caused by the pre-dose concentration???? ie. using the t1/2 and determine the amount of pre-dose concentration remaining throughout the timepoints and subtract it from the respective concentrations.


See above. I cannot imaging that any regulatory agency would accept this (any more).

❝ I remember one lab doing this and they said it's part of their SOP...


Referring to an SOP is alway the worst (pseudo-)justification I can think of.

“Hey, let’s jump from the cliff!” Lemming’s SOP


Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
92 visitors (0 registered, 92 guests [including 5 identified bots]).
Forum time: 22:54 CET (Europe/Vienna)

Nothing shows a lack of mathematical education more
than an overly precise calculation.    Carl Friedrich Gauß

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5